Share

July 21, 2020; 95 (3) Editorial

The quest for dementia prevention does not include an aspirin a day

David S. Knopman, Ronald C. Petersen
First published March 25, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009278
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
132

Share

Article Information

vol. 95 no. 3 105-106
DOI: 
https://doi.org/10.1212/WNL.0000000000009278
PubMed: 
32213641
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published March 25, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. David S. Knopman, MD and
    2. Ronald C. Petersen, PhD, MD
  1. David S. Knopman, MD and
    2. Scientific Advisory Boards:

    1. Consultant Bluefield project (frontotemporal dementia) ended 2018. DIAN study DSMB (Sept 2013 - July 2019).

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Omsbudsman Neurology, previously; Scientific Integrity officer, currently

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) A4 clinical trial partially funded by Lilly (site PI) (2) Biogen Alzheimer Study (site PI)

    Research Support, Government Entities:

    1. NIH: R01-AG11378 ongoing, P50-AG 16574 (Mayo Alzheimer’s Disease Research Center) ongoing, U01 AG 06786 (Mayo Alzheimer Disease Patient Registry) ongoing. 1U01HL096917-01 ARIC Dementia Study. AG 037551 Chronic Kidney Disease and Cognitive functioning.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ronald C. Petersen, PhD, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Mild Cognitive Impairment,Oxford University Press, 2003

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Roche Incorporated, (2) Merck, (3) Genentech (DSMB), (4) Biogen, (5) GE Healthcare (presentation) (6) Eisai, Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute on Aging: U01-AG006786 (PI) (1986-present) P50-AG016574 (PI) (1990-present) U01-AG024904 (PI) (2004-present) U01 AG016976 (PI) (1989 – present) P30 AG062677 (2019 - present)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Mayo Clinic, Rochester, MN.
  1. Correspondence
    Dr. Knopman knopman{at}mayo.edu
View Full Text

Article usage

Article usage: March 2020 to April 2023

AbstractFullPdfSource
Mar 2020365017Highwire
Apr 2020252015Highwire
May 20207407Highwire
Jun 20205005Highwire
Jul 20204565127Highwire
Aug 2020731315Highwire
Sep 20208214Highwire
Oct 20206836Highwire
Nov 20203868Highwire
Dec 20204123Highwire
Jan 20213005Highwire
Feb 20213413Highwire
Mar 20214513Highwire
Apr 20219312Highwire
May 20216301Highwire
Jun 20212922Highwire
Jul 20213911Highwire
Aug 20213400Highwire
Sep 20211611Highwire
Oct 20213400Highwire
Nov 20212600Highwire
Dec 20211812Highwire
Jan 20221900Highwire
Feb 20222421Highwire
Mar 20222900Highwire
Apr 20222600Highwire
May 20221900Highwire
Jun 20222500Highwire
Jul 20222201Highwire
Aug 20222000Highwire
Sep 20222000Highwire
Oct 20221300Highwire
Nov 20222900Highwire
Dec 202211033Highwire
Jan 20232200Highwire
Feb 20231300Highwire
Mar 20231700Highwire
Apr 20231700Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles